Salaera™ Launches as Global Powerhouse for Advanced Respiratory and Gas Analysis Technologies

Salaera unites Perma Pure and Maxtec into a global platform for advanced respiratory care, diagnostics, and high-fidelity industrial gas analysis.

By: AXL Media

Published: Apr 7, 2026, 6:00 AM EDT

Source: Information for this report was sourced from Salaera™

Salaera™ Launches as Global Powerhouse for Advanced Respiratory and Gas Analysis Technologies - article image
Salaera™ Launches as Global Powerhouse for Advanced Respiratory and Gas Analysis Technologies - article image

The Strategic Unification of Industry Leaders

The global landscape of respiratory and gas technology has undergone a major consolidation with the launch of Salaera. This new parent company marks the official unification of Perma Pure, a global authority in gas conditioning, and Maxtec, a leader in oxygen analysis and delivery. By integrating these established entities alongside Baldwin conditioning systems, Clayborn thermal-control technologies, and Bird® MicroBlenders, Salaera has created one of the most comprehensive gas-path portfolios in the industry. This structural shift allows the company to offer a "dual-path" capability, providing both custom-engineered OEM systems and ready-to-ship medical devices through a single integrated platform.

Harnessing 50 Years of Technical Expertise

The foundation of Salaera is built upon decades of proven technological performance in high-stakes environments. Perma Pure brings its exclusive Nafion™ polymer technology, which has served as the global standard for gas conditioning in critical applications for over 50 years. Maxtec contributes a legacy of trusted performance in neonatal and intensive care units (NICUs and ICUs), where its devices are essential for precise oxygen delivery. According to CEO Kathy Ouellette, the merger is a "strategic inflection point" that builds on this combined legacy to address the next era of air-focused health innovation and industrial analysis.

The Rise of Non-Invasive Breath Diagnostics

A primary driver for the formation of Salaera is the rapid expansion of breath-based diagnostics as a non-invasive source for biomarkers. Scientific shifts have increasingly positioned human breath as a window into respiratory diseases, infectious pathogens, and metabolic conditions. As hospitals transition toward more connected and data-rich monitoring systems, the need for high-precision gas pathways becomes critical. Salaera’s integrated expertise is designed to protect the integrity of these pathways, ensuring that the raw air captured in a clinical setting is stabilized and conditioned to provide accurate, actionable medical insights.

Categories

Topics

Related Coverage